TYRA - Balance Sheet - Tyra Biosciences, Inc.

Current Liabilities	14.6 M
Accounts Payable	590 K
Short-Term Debt	412 K
Other Current Liabilities	13.6 M
Non-Current Liabilities	5.81 M
Long-Term Debt	0
Other Non-Current Liabilities	5.81 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	92.0	58.0	251.2	302.2	15.2	0.1
Short Term Investments	249.5	145.5	0	0	0	0
Receivables	0	0	0	0	0	0
Inventory	0	0	0	0	0	0
Other Current Assets	6.0	8.2	6.1	3.8	57 K	19 K
Total Current Assets	347.5	211.7	257.3	304.1	15.3	0.1
PP&E	7.7	8.2	3.5	2.1	0.5	0.3
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	1.0	0.2	0.2	0
Other Long Term Assets	8.4	6.0	4.3	0.6	21 K	0.1
Other Assets	0	0	0	0	0	0
Total Assets	363.6	225.9	266.2	306.7	16.0	0.5
LIABILITIES
Accounts Payable	0.6	4.7	1.1	0.6	0.7	0.3
Short Term Debt	0.4	0.3	0.3	0.4	0.1	0.1
Other Current Liabilities	13.6	10.4	4.3	2.6	1.1	4.7
Total Current Liabilities	14.6	15.3	5.7	3.6	1.9	5.2
Long Term Debt	0	6.2	2.5	1.0	0	0.1
Deferred Tax Income	0	0	0	0.3	0	0
Other Liabilities	5.8	46 K	0.2	0.4	27.8	0
Total Liabilities	20.4	21.6	8.4	5.0	29.6	5.3
EQUITY
Common Stock	5 K	4 K	4 K	4 K	0	0
Retained Earnings	(251.3)	(164.8)	(95.7)	(40.4)	(14.1)	(4.7)
Other Accumulative Comprehensive Income/Loss	0.8	0.4	0	(306.7)	0	0
Total Equity	343.2	204.3	(95.7)	301.7	(13.6)	(4.7)
Total Liabilities and Equity	363.6	225.9	(87.3)	306.7	16.0	0.5
SHARES OUTSTANDING
Common Shares Outstanding	57.2	42.7	41.9	41.4	42.5	42.5

Free